Bleakley Platt Partner Janet Linn quoted in IP Law 360

February 2015

On January 21, 2015, Janet Linn, an intellectual property litigation partner at Bleakley Platt, was quoted in IP Law 360.  Ms. Linn commented on the significance of the Supreme Court’s decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (Jan. 20, 2015), deciding the appropriate standard of appellate review of the factual findings underlying the district court’s claim construction in a patent litigation.  She observed that the decision to accord deference to the findings should result in more detailed and thorough District Court claim construction opinions, providing the litigants, and the Federal Circuit on an appeal, a better understanding of the District Court’s reasoning.